Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

236
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
236
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

210
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
210
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

316
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
316
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

280
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
280
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

233
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
233
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

129
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
129

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacologic Thromboprophylaxis in Medical Inpatients: A Systematic Review and Network Meta-Analysis.

JAMA network open·2026
Same author

Pregnancy-associated venous thromboembolism-still undefeated.

Journal of thrombosis and haemostasis : JTH·2026
Same author

[The Role of Nailfold Capillaroscopy in Raynaud's Phenomenon and Autoimmune Diseases].

Revue medicale suisse·2026
Same author

[Bone sarcoidosis: an underrecognized manifestation of a multisystemic disease].

Revue medicale suisse·2026
Same author

Comparison of Three Diagnostic Strategies for Suspicion of Pulmonary Embolism: Planar Ventilation-Perfusion Scan (V/Q), Computed Tomography Pulmonary Angiography (CTPA), and Single Photon Emission Computed Tomography Ventilation-Perfusion Scan (SPECT V/Q): a multicenter, non-inferiority randomised controlled trial.

The European respiratory journal·2026
Same author

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.

The New England journal of medicine·2026

Related Experiment Video

Updated: Dec 30, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.5K

[How to manage giant cell arteritis].

Danièle Allali1, Marc Blondon1, Pascale Roux-Lombard1

  • 1Service d'immunologie et d'allergologie, HUG, 1211 Genève 14.

Revue Medicale Suisse
|January 22, 2020
PubMed
Summary
This summary is machine-generated.

Giant cell arteritis (GCA) diagnosis is crucial for timely corticosteroid treatment. Newer therapies like tocilizumab and methotrexate offer alternatives, reducing steroid dependence and relapses in GCA patients.

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

738
Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
07:21

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices

Published on: September 8, 2023

987

Related Experiment Videos

Last Updated: Dec 30, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.5K
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

738
Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
07:21

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices

Published on: September 8, 2023

987

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Vasculitis Research

Background:

  • Giant cell arteritis (GCA) is the most prevalent vasculitis affecting individuals over 50.
  • Prompt corticosteroid treatment is essential to prevent ischemic complications associated with GCA.
  • The need for accurate diagnosis is heightened due to the significant side effects of long-term corticosteroid therapy.

Purpose of the Study:

  • To review current diagnostic standards for GCA, including imaging and clinical criteria.
  • To explore established and emerging therapeutic strategies for managing GCA.
  • To discuss the role of tocilizumab, methotrexate, abatacept, and ustekinumab in GCA treatment.

Main Methods:

  • Review of histological confirmation as the gold standard for GCA diagnosis.
  • Evaluation of non-invasive imaging techniques, particularly temporal artery ultrasound.
  • Analysis of clinical studies and regulatory approvals for GCA therapies.

Main Results:

  • Temporal artery ultrasound and specific clinical criteria provide reliable non-invasive GCA diagnosis.
  • Tocilizumab, in combination with corticosteroids, is approved for GCA treatment.
  • Methotrexate has demonstrated efficacy in reducing corticosteroid dosage and relapse rates.

Conclusions:

  • Accurate diagnosis of GCA is paramount to guide appropriate and timely treatment.
  • Tocilizumab and methotrexate represent significant advancements in GCA management, offering steroid-sparing options.
  • Emerging therapies like abatacept and ustekinumab hold promise for future GCA treatment protocols.